Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BWX Technologies (BWXT) Research & Development (2016 - 2025)

BWX Technologies (BWXT) has disclosed Research & Development for 16 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 44.54% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, up 85.44% year-over-year, with the annual reading at $13.9 million for FY2025, 85.44% up from the prior year.
  • Research & Development for Q4 2025 was $3.8 million at BWX Technologies, up from $3.5 million in the prior quarter.
  • The five-year high for Research & Development was $4.6 million in Q2 2025, with the low at $1.2 million in Q3 2023.
  • Average Research & Development over 5 years is $2.5 million, with a median of $2.6 million recorded in 2022.
  • The sharpest move saw Research & Development plummeted 51.02% in 2024, then soared 259.17% in 2025.
  • Over 5 years, Research & Development stood at $1.6 million in 2021, then soared by 62.31% to $2.5 million in 2022, then tumbled by 34.85% to $1.7 million in 2023, then skyrocketed by 58.99% to $2.6 million in 2024, then soared by 44.54% to $3.8 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $3.8 million, $3.5 million, and $4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.